Loading clinical trials...
Loading clinical trials...
A Phase 1, Multicenter, Open-Label, Parallel-Group Study to Assess the Safety and Pharmacokinetics of Oral Epetraborole Tablets in Adult Subjects With Varying Degrees of Renal Function
Conditions
Interventions
Epetraborole
Locations
3
United States
Advanced Pharma CR
Miami, Florida, United States
Orlando Clinical Research Center
Orlando, Florida, United States
Nucleus Network
Saint Paul, Minnesota, United States
Start Date
February 21, 2022
Primary Completion Date
June 10, 2022
Completion Date
June 27, 2022
Last Updated
July 15, 2022
NCT07262333
NCT01524276
NCT07203131
NCT02769975
NCT06660277
NCT06314503
Lead Sponsor
AN2 Therapeutics, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions